Walder Wyss advised Merck on the deal, and Baker Mckenzie advised Chord Therapeutics SA.Merck entered into an agreement to acquire Chord Therapeutics SA, a Swiss-based biotech…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
